Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125359992 | 12535999 | 2 | F | 20160523 | 20160707 | 20160707 | EXP | US-CIPLA LTD.-2016US06025 | CIPLA | 0.00 | Y | 0.00000 | 20160707 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125359992 | 12535999 | 1 | PS | AMLODIPINE | AMLODIPINE BESYLATE | 1 | Unknown | UNK | U | 77073 | TABLET | ||||||||
| 125359992 | 12535999 | 2 | C | HYDROCHLOROTHIAZIDE. | HYDROCHLOROTHIAZIDE | 1 | Unknown | 12.5 MG, QD | U | U | 0 | 12.5 | MG | ||||||
| 125359992 | 12535999 | 3 | C | EXFORGE | AMLODIPINE BESYLATEVALSARTAN | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125359992 | 12535999 | 1 | Hypertension |
| 125359992 | 12535999 | 2 | Hypertension |
| 125359992 | 12535999 | 3 | Hypertension |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125359992 | 12535999 | Drug ineffective | |
| 125359992 | 12535999 | Product substitution issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |